Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
EJNMMI Research
|
February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
Wenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
BMC Cancer
|
March 8, 2017
The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients
Shengjie Guo, Xiaobo He, Qian Chen, et al.
Medcomm
|
November 12, 2021
A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2
Yibo Zhang, Man Ouyang, Hailong Wang, et al.
Stem Cells (Dayton, Ohio)
|
July 3, 2013
Reversing bone loss by directing mesenchymal stem cells to bone
Wei Yao, Min Guan, Junjing Jia, et al.
Frontiers in Pharmacology
|
March 20, 2023
Engineered multi-functional, pro-angiogenic collagen-based scaffolds loaded with endothelial cells promote large deep burn wound healing
Hengyue Song, Kewa Gao, Dake Hao, et al.
Medicine
|
March 26, 2016
The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study
Shengjie Guo, Xiaobo He, Qian Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2018
Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
Tsung-Chieh Shih, Ruiwu Liu, Chun-Te Wu, et al.
Bioactive Materials
|
June 6, 2022
A bioactive material with dual integrin-targeting ligands regulates specific endogenous cell adhesion and promotes vascularized bone regeneration in adult and fetal bone defects
Dake Hao, Ruiwu Liu, Tomas Gonzalez Fernandez, et al.
Plos One
|
August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors
Wenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
Journal of Dermatological Science
|
April 25, 2017
ITK inhibition for the targeted treatment of CTCL
Itzel Bustos-Villalobos, Jennifer Williams Bergstrom, Nathan E Haigh, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
EJNMMI Research
|
February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
Wenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
BMC Cancer
|
March 8, 2017
The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients
Shengjie Guo, Xiaobo He, Qian Chen, et al.
Medcomm
|
November 12, 2021
A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2
Yibo Zhang, Man Ouyang, Hailong Wang, et al.
Stem Cells (Dayton, Ohio)
|
July 3, 2013
Reversing bone loss by directing mesenchymal stem cells to bone
Wei Yao, Min Guan, Junjing Jia, et al.
Frontiers in Pharmacology
|
March 20, 2023
Engineered multi-functional, pro-angiogenic collagen-based scaffolds loaded with endothelial cells promote large deep burn wound healing
Hengyue Song, Kewa Gao, Dake Hao, et al.
Medicine
|
March 26, 2016
The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study
Shengjie Guo, Xiaobo He, Qian Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2018
Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
Tsung-Chieh Shih, Ruiwu Liu, Chun-Te Wu, et al.
Bioactive Materials
|
June 6, 2022
A bioactive material with dual integrin-targeting ligands regulates specific endogenous cell adhesion and promotes vascularized bone regeneration in adult and fetal bone defects
Dake Hao, Ruiwu Liu, Tomas Gonzalez Fernandez, et al.
Plos One
|
August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors
Wenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
Journal of Dermatological Science
|
April 25, 2017
ITK inhibition for the targeted treatment of CTCL
Itzel Bustos-Villalobos, Jennifer Williams Bergstrom, Nathan E Haigh, et al.
Page
of 11